Viviana Boronat

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
RATIONALE Saphenous vein graft disease remains a major limitation of coronary artery bypass graft surgery (CABG). Statin therapy inhibits the development of vein graft disease and improves outcomes after CABG. However, it is unclear whether treatment with high-dose statins will further slow the process of vein graft disease and improve graft patency, as(More)
  • 1